•Young employees have lower rates of chronic disease than older people. However, their perception, treatment rate, and control rates for their disease are about half that of the elderly.
•In the previous study, we observed the results of improving obesity, diabetes, metabolic syndrome using mobile. In some cases, the effectiveness of workplace health care programs was confirmed, but most of them were fragmented health care services.
•In addition, there is a lack of research data on the effects of systematic health management programs integrating online and offline.
•Therefore, we aim to verify the improvement of cardiovascular risk factors (metabolism syndrome, obesity) using SHP online and offline integration program.

Prevention

•We will divide the subjects enrolled by the inclusion and exclusion criteria into three groups.
•We will randomize subjects in the same proportions to Intervention Group 1 (Basic Healthcare Program + Mobile Application), Intervention Group 2 (Basic Healthcare Program + Mobile + SHP Offline Service) and Control Group (Basic Healthcare Program).

Arm Label

Target Number of Participant

Arm Type

Arm Description

Providing online coaching services through SHP applications

Arm Label

Target Number of Participant

Arm Type

Arm Description

Providing online coaching services through SHP applications and group exercise (additional offline intervention)

Gender

Age

Description

1) Age: over 20 years old
2) body mass index (BMI) ≥ 25 kg / m2
3) Metabolic Syndrome
        * Those who meet 3 or more of the following 5 elements 
        (1) abdominal obesity: waist ≥ 90 cm (male), 85 cm (female)
        (2) blood pressure ≥ 130/85 mmHg
        (3) fasting blood sugar ≥ 100 mg / dL
        (4) triglyceride ≥ 150 mg / dL  or Patients taking fibrate medications
        (5) high-density lipoprotein cholesterol (HDL-C) <40 mg /dL (male), 50 mg /dL (Female)
4) Patients who can understand, read, and write the purpose of clinical research
5) Patients who can use the smartphone application used for clinical research
6) Patients who voluntarily participate and sign a consent form

1) Participants in a diet or weight loss healthcare program within 12 weeks prior to the screening visit
2) Patients who are currently in hospital or are expected to need hospitalization within the clinical study period
3) Patients diagnosed with myocardial infarction or stroke within the last year
4) Patients with end stage renal failure who need renal replacement therapy
   Serum creatine levels are more than 1.5 times the upper limit of normal
5) Pregnant women
6) Liver Failure (Severe Liver Disorder Patients)
    Serum liver enzyme (AST or ALT) is more than five times the upper limit of normal
7) Uncontrolled chronic lung disease
8) Phentermin, orlistat 등 항비만약물 치료 중이거나 예정인 환자
9) Patients taking drugs that may affect their weight (eg psychiatric drugs)
10) Patients who have a medical condition that is likely to affect clinical research results, such as clinically significant neurological disease, gastrointestinal disease, or malignant tumor, or are inappropriate for participation in clinical research, as judged by the investigator.
11) Participants in other clinical studies (excluding observational studies) within 12 weeks before the screening visit
12) Type I and Type II Diabetics requiring Insulin Treatment
13) Participants who have had a weight change of more than 10% of their weight in the last year

Changes in body weight, body mass index, and metabolic syndrome prevalence

after 12 weeks from baseline and 1-year follow-up

Test results and lifestyle changes related to obesity and metabolic syndrome, including blood pressure, serum lipids, liver function, uric acid, blood sugar, and insulin resistance

after 12 weeks from baseline and 1-year follow-up